Cargando…
Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload
BACKGROUND: Thalassaemia major (TM) patients need regular blood transfusions that lead to accumulation of iron and death from heart failure. Deferiprone has been reported to be superior to deferoxamine for the removal of cardiac iron and improvement in left ventricular (LV) function but little is kn...
Autores principales: | Smith, Gillian C, Alpendurada, Francisco, Carpenter, John Paul, Alam, Mohammed H, Berdoukas, Vasili, Karagiorga, Markissia, Ladis, Vasili, Piga, Antonio, Aessopos, Athanassios, Gotsis, Efstathios D, Tanner, Mark A, Westwood, Mark A, Galanello, Renzo, Roughton, Michael, Pennell, Dudley J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148987/ https://www.ncbi.nlm.nih.gov/pubmed/21733147 http://dx.doi.org/10.1186/1532-429X-13-34 |
Ejemplares similares
-
Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major
por: Alpendurada, Francisco, et al.
Publicado: (2012) -
Comparison of echocardiographic (US) volumetry with cardiac magnetic resonance (CMR) imaging in transfusion dependent thalassemia major (TM)
por: Giakoumis, Anastasios, et al.
Publicado: (2007) -
Successful chelation in beta-thalassemia major in the 21(st) century
por: Fragodimitri, Christina, et al.
Publicado: (2023) -
Treating thalassemia major-related iron overload: the role of deferiprone
por: Berdoukas, Vasilios, et al.
Publicado: (2012) -
Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective
por: Galanello, Renzo
Publicado: (2007)